Engineered mutation of some important amino acids in angiotensin II type 1 (AT1) receptor increases the binding affinity of AT1-receptor antagonists.

Source:http://linkedlifedata.com/resource/pubmed/id/20453435

Download in:

View as

Triples

General Info

PMID
20453435